申请人:Gerson Stanton L.
公开号:US20120065145A1
公开(公告)日:2012-03-15
This application provides compositions and methods useful in the treatment of certain cancers. In part, this application is based on the recognition that certain molecules that target abasic lesions or AP sites in DNA improve, augment, or potentiate the chemotherapeutic efficacy of certain anticancer agents.